US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jul 11, 2022 (4 years ago)

Lorazepam Injection, USP, 2mg/mL, 1 mL vial, 25 vial per carton, Rx Only, Novaplus…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Impurities/Degradation Specifications: Out-of-specification results observed for total related compounds during testing of retain samples.

What was recalled

Lorazepam Injection, USP, 2mg/mL, 1 mL vial, 25 vial per carton, Rx Only, Novaplus, Manufactured by Hikma Berkeley Heights, NJ 07922. Carton NDC# 0641-6048-25, Vial NDC# 0641-6048-01

Recalling firm
Hikma Pharmaceuticals USA Inc.
NDC code
0641-6048-25
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1309-2022

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Lorazepam recalls

See all